Marshall Wace, LLP Agilent Technologies, Inc. Transaction History

Marshall Wace, LLP

$77.3 Billion
Q3 2024

A detailed history of Marshall Wace, LLP transactions in Agilent Technologies, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 212,151 shares of A stock, worth $28.5 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

212,151

Previous 957,128 77.83%

Holding current value

$28.5 Million

Previous $124 Million 74.61%

% of portfolio

0.04%

Previous 0.17%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$125.42 - $148.48 $93.4 Million - $111 Million	-744,977 Reduced 77.83%	212,151 $31.5 Million
Q2 2024 Aug 14, 2024	BUY	$129.63 - $154.64 $40.6 Million - $48.4 Million	313,155 Added 48.63%	957,128 $124 Million
Q1 2024 May 15, 2024	SELL	$128.12 - $149.31 $58.3 Million - $68 Million	-455,354 Reduced 41.42%	643,973 $93.7 Million
Q4 2023 Feb 14, 2024	BUY	$101.17 - $139.82 $32.9 Million - $45.4 Million	324,859 Added 41.95%	1,099,327 $153 Million
Q3 2023 Nov 14, 2023	BUY	$109.73 - $128.47 $7.12 Million - $8.33 Million	64,876 Added 9.14%	774,468 $86.6 Million
Q2 2023 Aug 14, 2023	SELL	$114.69 - $141.28 $17.2 Million - $21.2 Million	-149,726 Reduced 17.42%	709,592 $85.3 Million
Q1 2023 May 15, 2023	SELL	$131.13 - $159.06 $75.7 Million - $91.9 Million	-577,624 Reduced 40.2%	859,318 $119 Million
Q4 2022 Feb 14, 2023	SELL	$125.64 - $157.68 $23.3 Million - $29.3 Million	-185,569 Reduced 11.44%	1,436,942 $215 Million
Q3 2022 Nov 14, 2022	BUY	$115.11 - $142.29 $36 Million - $44.5 Million	312,836 Added 23.89%	1,622,511 $197 Million
Q2 2022 Aug 15, 2022	BUY	$112.71 - $135.93 $25.6 Million - $30.9 Million	227,188 Added 20.99%	1,309,675 $156 Million
Q1 2022 May 16, 2022	BUY	$126.0 - $156.48 $136 Million - $169 Million	1,082,487 New	1,082,487 $143 Million
Q2 2021 Aug 13, 2021	SELL	$127.69 - $148.81 $56.6 Million - $66 Million	-443,403 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$114.99 - $130.12 $72.2 Million - $81.7 Million	-627,810 Reduced 58.61%	443,403 $56.4 Million
Q4 2020 Feb 16, 2021	SELL	$100.01 - $119.3 $124 Million - $147 Million	-1,235,472 Reduced 53.56%	1,071,213 $127 Million
Q3 2020 Nov 16, 2020	BUY	$88.11 - $103.42 $64.9 Million - $76.2 Million	736,536 Added 46.91%	2,306,685 $233 Million
Q2 2020 Aug 13, 2020	SELL	$68.92 - $91.14 $41.9 Million - $55.4 Million	-607,367 Reduced 27.89%	1,570,149 $139 Million
Q1 2020 May 15, 2020	BUY	$63.37 - $90.13 $73.6 Million - $105 Million	1,162,083 Added 114.44%	2,177,516 $156 Million
Q4 2019 Feb 14, 2020	BUY	$72.49 - $85.45 $73.5 Million - $86.7 Million	1,014,524 Added 111608.8%	1,015,433 $86.6 Million
Q3 2019 Nov 14, 2019	SELL	$65.59 - $78.07 $35.9 Million - $42.7 Million	-546,787 Reduced 99.83%	909 $70,000
Q2 2019 Aug 14, 2019	SELL	$66.89 - $81.94 $44.4 Million - $54.4 Million	-664,194 Reduced 54.81%	547,696 $40.9 Million
Q1 2019 May 14, 2019	SELL	$63.27 - $82.0 $101 Million - $131 Million	-1,600,660 Reduced 56.91%	1,211,890 $97.4 Million
Q4 2018 Feb 14, 2019	BUY	$61.13 - $74.67 $9.97 Million - $12.2 Million	163,048 Added 6.15%	2,812,550 $190 Million
Q3 2018 Nov 14, 2018	BUY	$61.25 - $71.13 $102 Million - $119 Million	1,668,360 Added 170.04%	2,649,502 $187 Million
Q2 2018 Aug 14, 2018	BUY	$61.14 - $69.55 $56.9 Million - $64.7 Million	930,356 Added 1831.91%	981,142 $60.7 Million
Q1 2018 May 15, 2018	SELL	$65.05 - $74.82 $12.1 Million - $13.9 Million	-185,981 Reduced 78.55%	50,786 $3.4 Million
Q4 2017 Feb 14, 2018	BUY	$64.87 - $70.59 $14.3 Million - $15.5 Million	219,743 Added 1290.78%	236,767 $15.9 Million
Q3 2017 Nov 13, 2017	BUY	$58.57 - $66.17 $997,095 - $1.13 Million	17,024	17,024 $1.09 Million

Others Institutions Holding A

# of Institutions

1,148

Shares Held

252M

Call Options Held

729K

Put Options Held

970K

View Full List

About AGILENT TECHNOLOGIES, INC.

Ticker A
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 296,040,992
Market Cap $39.8B
Description
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatogra...

More about A

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Agilent Technologies, Inc. Transaction History